| Ticker Details |
|
Eton Pharmaceuticals, Inc. Common Stock
|
| IPO Date: |
November 13, 2018 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$1.14B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.28 | 3.17%
|
| Avg Daily Range (30 D): |
$1.94 | 4.51%
|
| Avg Daily Range (90 D): |
$1.23 | 3.50%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.2M |
| Avg Daily Volume (30 D): |
.49M |
| Avg Daily Volume (90 D): |
.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
106 |
| Avg Trade Size (Sh.) (30 D): |
55 |
| Avg Trade Size (Sh.) (90 D): |
54 |
| Institutional Trades |
| Total Institutional Trades: |
217 |
| Avg Institutional Trade: |
$1.74M |
| Avg Institutional Trade (30 D): |
$2.3M |
| Avg Institutional Trade (90 D): |
$1.96M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.86M |
| Avg Closing Trade (30 D): |
$2.47M |
| Avg Closing Trade (90 D): |
$1.91M |
| Avg Closing Volume: |
88.91K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$.47
|
$.42
|
$.06
|
|
Diluted EPS
|
|
$.35
|
$.05
|
|
Revenue
|
$105.6M
|
$37.59M
|
$24.27M
|
|
Gross Profit
|
$61.1M
|
$25.41M
|
$14.74M
|
|
Net Income / Loss
|
$12.69M
|
$11.58M
|
$1.55M
|
|
Operating Income / Loss
|
$16.31M
|
$12.79M
|
$2.41M
|
|
Cost of Revenue
|
$44.49M
|
$12.18M
|
$9.53M
|
|
Net Cash Flow
|
$11.91M
|
$7.18M
|
$-6.28M
|
|
PE Ratio
|
|
|
|
|
|
|